These results suggest that miR-548ag could promote the expression of DPP4 in hepatocytes via targeted downregulation of DNMT3B after the onset of obesity, which could eventually lead to glucose metabolism disorder. Here, DPP4 is linked to obesity due to melanocortin 4 receptor deficiency.